Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/33785
Full metadata record
DC FieldValueLanguage
dc.contributor.authorÇavuşoğlu, Yüksel-
dc.contributor.authorZoghi, Mehdi-
dc.contributor.authorEren, Mehmet-
dc.contributor.authorBozcali, Evin-
dc.contributor.authorKozdağ, Güliz-
dc.contributor.authorAlicik, Güray-
dc.contributor.authorSoylu, Korhan-
dc.contributor.authorSarı, İbrahim-
dc.contributor.authorBerilgen, Rida-
dc.contributor.authorTemizhan, Ahmet-
dc.contributor.authorGencer, Erkan-
dc.contributor.authorOrhan, Ahmet Lütfü-
dc.contributor.authorPolat, Veli-
dc.contributor.authorAktoz, Meryem-
dc.contributor.authorZengin, Halit-
dc.contributor.authorAksoy, Mehmet-
dc.contributor.authorSelçuk, Mehmet Timur-
dc.contributor.authorErgene, Oktay-
dc.contributor.authorSoran, Özlem-
dc.date.accessioned2023-09-07T13:03:44Z-
dc.date.available2023-09-07T13:03:44Z-
dc.date.issued2016-02-19-
dc.identifier.citationÇavuşoğlu, Y. vd. (2017). ''Post-discharge heart failure monitoring program in Turkey: Hit-PoinT''. Anatolian Journal of Cardiology, 17(2), 107-112.tr_TR
dc.identifier.issn2149-2263-
dc.identifier.issn2149-2271-
dc.identifier.urihttps://doi.org/10.14744/AnatolJCardiol.2016.6812-
dc.identifier.urihttps://anatoljcardiol.com/jvi.aspx?un=AJC-17992-
dc.identifier.urihttp://hdl.handle.net/11452/33785-
dc.description.abstractObjective: The aim of this study was to assess the efficacy and feasibility of an enhanced heart failure (HF) education with a 6-month telephone follow- up program in post-discharge ambulatory HF patients. Methods: The Hit-Point trial was a multicenter, randomized, controlled trial of enhanced HF education with a 6-month telephone follow-up program (EHFP) vs routine care (RC) in patients with HF and reduced ejection fraction. A total of 248 patients from 10 centers in various geographical areas were randomized: 125 to EHFP and 123 to RC. Education included information on adherence to treatment, symptom recognition, diet and fluid intake, weight monitoring, activity and exercise training. Patients were contacted by telephone after 1, 3, and 6 months. The primary study endpoint was cardiovascular death. Results: Although all-cause mortality didn't differ between the EHFP and RC groups (p=NS), the percentage of cardiovascular deaths in the EHFP group was significantly lower than in the RC group at the 6-month follow up (5.6% vs. 8.9%, p=0.04). The median number of emergency room visits was one and the median number of all cause hospitalizations and heart failure hospitalizations were zero. Twenty-tree percent of the EHFP group and 35% of the RC group had more than a median number of emergency room visits (p=0.05). There was no significant difference regarding the median number of all-cause or heart failure hospitalizations. At baseline, 60% of patients in EHFP and 61% in RC were in NYHA Class III or IV, while at the 6-month follow up only 12% in EHFP and 32% in RC were in NYHA Class III or IV (p=0.001). Conclusion: These results demonstrate the potential clinical benefits of an enhanced HF education and follow up program led by a cardiologist in reducing cardiovascular deaths and number of emergency room visits with an improvement in functional capacity at 6 months in post-discharge ambulatory HF patients.en_US
dc.description.sponsorshipTürk Kardiyoloji Derneği Kalp Yetmezliği Çalışma Grubutr_TR
dc.language.isoenen_US
dc.publisherKare Yayıncılıktr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAtıf Gayri Ticari Türetilemez 4.0 Uluslararasıtr
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCardiovascular system & cardiologyen_US
dc.subjectHeart failureen_US
dc.subjectDisease managementen_US
dc.subjectCardiovascularen_US
dc.subjectHealth educationen_US
dc.subjectOutcomesen_US
dc.subjectDisease management programsen_US
dc.subjectOlder patientsen_US
dc.subjectFollow-upen_US
dc.subjectHigh-risken_US
dc.subjectCaresyen_US
dc.subjectStemen_US
dc.subjectAdmissionen_US
dc.subjectTrialen_US
dc.subjectInterventionen_US
dc.subjectMetaanalysisen_US
dc.subject.meshFemaleen_US
dc.subject.meshHeart failureen_US
dc.subject.meshHumansen_US
dc.subject.meshInterviews as topicen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle ageden_US
dc.subject.meshPatient dischargeen_US
dc.subject.meshPatient education as topicen_US
dc.subject.meshTreatment outcomeen_US
dc.subject.meshTurkeyen_US
dc.titlePost-discharge heart failure monitoring program in Turkey: Hit-PoinTen_US
dc.typeArticleen_US
dc.identifier.wos000396901400006tr_TR
dc.identifier.scopus2-s2.0-85015290690tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı.tr_TR
dc.identifier.startpage107tr_TR
dc.identifier.endpage112tr_TR
dc.identifier.volume17tr_TR
dc.identifier.issue2tr_TR
dc.relation.journalAnatolian Journal of Cardiologyen_US
dc.contributor.buuauthorŞentürk, Tunay-
dc.contributor.buuauthorKaderli, Aysel Aydın-
dc.contributor.researcheridC-1517-2017tr_TR
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.identifier.pubmed27488754tr_TR
dc.subject.wosCardiac & cardiovascular systemsen_US
dc.indexed.wosCPCISen_US
dc.indexed.scopusScopusen_US
dc.wos.quartileQ3en_US
dc.contributor.scopusid8342098300tr_TR
dc.contributor.scopusid7801322152tr_TR
dc.subject.scopusHeart Failure; E-Health; Hospital Readmissionen_US
dc.subject.emtreeAngiotensin receptor antagonisten_US
dc.subject.emtreeAntiarrhythmic agenten_US
dc.subject.emtreeBeta adrenergic receptor blocking agenten_US
dc.subject.emtreeCalcium channel blocking agenten_US
dc.subject.emtreeDigoxinen_US
dc.subject.emtreeDipeptidyl carboxypeptidase inhibitoren_US
dc.subject.emtreeDiuretic agenten_US
dc.subject.emtreeNitrateen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCardiovascular mortalityen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeEmergency warden_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeFunctional statusen_US
dc.subject.emtreeHealth educationen_US
dc.subject.emtreeHeart failureen_US
dc.subject.emtreeHeart failure with reduced ejection fractionen_US
dc.subject.emtreeHeart left ventricle ejection fractionen_US
dc.subject.emtreeHospital dischargeen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHyperlipidemiaen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeMulticenter studyen_US
dc.subject.emtreePatient educationen_US
dc.subject.emtreeRandomized controlled trialen_US
dc.subject.emtreeTurkey (republic)en_US
dc.subject.emtreeClinical trialen_US
dc.subject.emtreeHeart failureen_US
dc.subject.emtreeHospital dischargeen_US
dc.subject.emtreeInterviewen_US
dc.subject.emtreeMiddle ageden_US
dc.subject.emtreeMortalityen_US
dc.subject.emtreePatient educationen_US
dc.subject.emtreeTreatment outcomeen_US
dc.subject.emtreeTurkey (bird)en_US
Appears in Collections:Scopus
TrDizin
Web of Science

Files in This Item:
File Description SizeFormat 
Çavuşoğlu_vd_2017.pdf82.29 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons